Expert panel addresses GLP-1 RAs’ factors, features, and future
From the article
Amid increasing attention for GLP-1 RAs, a panel of experts summarized a broad spectrum of topics related to these medications, including emerging pharmacological options, muscle physiology, obesity treatment for osteoarthritis, and nutritional counseling. The post Expert panel addresses GLP-1 RAs’ factors, features, and future appeared first on ADA Meeting News .
Continue reading on adameetingnews.orgYou might also wanna read
National Psoriasis Foundation Review Examines GLP-1 Receptor Agonists for Psoriasis with Metabolic Comorbidities
This review from the US National Psoriasis Foundation Medical Board provides an evidence-informed narrative synthesis on GLP-1 receptor agon
doi.org·1mo agoEffects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS
clinicaltrials.gov·2d ago
ADA 2026 Scientific Sessions: New GLP-1 Drugs and Diabetes Research Highlights
In this JAMA Medical News podcast, Jennifer Abbasi interviews Dr. Rita Kalyani, the ADA's Chief Scientific and Medical Officer, about key hi
ja.ma·19d ago
GLP-1 Receptor Agonists Linked to Small Risk of Smell and Taste Disturbances in Type 2 Diabetes
A study published in JAMA Otolaryngology-Head & Neck Surgery found that GLP-1 receptor agonists (RAs) used for type 2 diabetes are associate
mdsc.pe·7d ago
Obesity care's next generation will combine GLP-1 drugs with personalized therapies and advanced procedures
The article discusses how GLP-1 drugs like Ozempic, Wegovy, and Zepbound have transformed obesity treatment, but experts predict the future
scitechdaily.com·12h ago
Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows
This article from Verge's Optimizer newsletter examines how health tech companies are marketing products specifically to GLP-1 drug users (p
theverge.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.